Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TRYPF
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Tryp Therapeutics Inc. stock price ended at $0.0562 on Thursday, after losing 0%.
(Updated on May 23, 2024)

Buy or Hold candidate since Apr 09, 2024 Gain 133.20% PDF

No changes to the price of Tryp Therapeutics Inc. stock on the last trading day (Thursday, 23rd May 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0562 to a day high of $0.0562. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 256.42% during the next 3 months and, with a 90% probability hold a price between $0.153 and $0.255 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TRYPF Signals & Forecast

The Tryp Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0562 and $0.0452. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 22, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Tryp Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0490 and $0.0470. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tryp Therapeutics Inc. finds support just below today's level at $0.0490. If this is broken, then the next support from accumulated volume will be at $0.0470 and $0.0429.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.0540 (-4.00%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (TRYPF) For The Upcoming Trading Day Of Friday 24th

For the upcoming trading day on Friday, 24th we expect Tryp Therapeutics Inc. to open at $0.0562, and during the day (based on 14 day Average True Range), to move between $0.0543 and $0.0581, which gives a possible trading interval of +/-$0.0019 (+/-3.34%) up or down from last closing price. If Tryp Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.68% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.0490, some $0.0072 (12.81%) from the current price of $0.0562, our system finds the risk reward attractive.

Is Tryp Therapeutics Inc. stock A Buy?

Tryp Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Tryp Therapeutics Inc. of Friday, May 24, 2024

Fair opening price May 24, 2024 Current price
$0.0562 ( 0%) $0.0562

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TRYPF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0562 .
R2 0.0562 .
R1 0.0562 .
Current price: 0.0562
Support S1 0.0562 .
S2 0.0562 .
S3 0.0562 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.0562
Support S1 0.0490 -12.81%
S2 0.0470 -16.37%
S3 0.0429 -23.67%

FAQ

What is the symbol for Tryp Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Tryp Therapeutics Inc. is TRYPF and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Tryp Therapeutics Inc. Stock?
Tryp Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Tryp Therapeutics Inc. Stock?
Tryp Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tryp Therapeutics Inc. Stock.

What's the current price of Tryp Therapeutics Inc. Stock?
As of the end of day on the May 23, 2024, the price of an Tryp Therapeutics Inc. (TRYPF) share was $0.0562.

What is the 52-week high and low for Tryp Therapeutics Inc. Stock?
The 52-week high for Tryp Therapeutics Inc. Stock is $0.0919 and the 52-week low is $0.0041.

What is the market capitalization of Tryp Therapeutics Inc. Stock?
As of the May 23, 2024, the market capitalization of Tryp Therapeutics Inc. is 5.419M.
Click to get the best stock tips daily for free!

About Tryp Therapeutics Inc.

Tryp Therapeutics. Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndro... TRYPF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT